NEW YORK, Dec. 6, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from […]
Insights
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec. 6, 2025 /PRNewswire/ — MENU – ORDER AI, the first real-time GLP-1 dining companion designed […]
Using the original title “Hep B Free – Calls for Continued Universal Hepatitis B Birth-Dose Vaccination Despite Federal Advisory Shift”, create a new title that is SEO-optimized, engaging, and fewer than 15 words. Incorporate the main focus keyword naturally and ensure the title accurately reflects the essence of the original. Do not include any part of this prompt or instructions in your response. Only provide the rewritten title. Avoid using the phrases: “rewrite,” “rewrite the title,” or “rewrite the following content.”
Transform the following content into a 1,500-word article: SAN FRANCISCO, Calif., Dec. 6, 2025 /PRNewswire/ — Hep B Free (Formerly SF Hep B Free – Bay Area) urges hospitals, clinicians, and public-health agencies to continue the […]
Hep B Free – Calls for Continued Universal Hepatitis B Birth-Dose Vaccination Despite Federal Advisory Shift
SAN FRANCISCO, Calif., Dec. 6, 2025 /PRNewswire/ — Hep B Free (Formerly SF Hep B Free – Bay Area) urges hospitals, clinicians, and public-health agencies to continue the universal newborn hepatitis B (Hep B) birth-dose vaccine […]
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
New long-term data presented at AES 2025 indicate reductions in seizure frequency are maintained for up to two years after treatment initiation with bexicaserin in patients with Developmental and Epileptic Encephalopathies (DEEs)1 DEEs are a group […]
